My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 161

    1.

    Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial.

    Tasker SA, Treanor JJ, Paxton WB, Wallace MR.

    Ann Intern Med. 1999 Sep 21;131(6):430-3.PMID: 10498559 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.

    Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ.

    J Infect Dis. 1996 Dec;174(6):1332-6.PMID: 8940228 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial.

    Tasker SA, O'Brien WA, Treanor JJ, Weiss PJ, Olson PE, Kaplan AH, Wallace MR.

    Vaccine. 1998 May-Jun;16(9-10):1039-42.PMID: 9682356 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of influenza vaccination on disease progression among HIV-infected persons.

    Sullivan PS, Hanson DL, Dworkin MS, Jones JL, Ward JW; Adult and Adolescent Spectrum of HIV Disease Investigators.

    AIDS. 2000 Dec 1;14(17):2781-5.PMID: 11125897 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

    King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

    Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.PMID: 11740317 [PubMed - indexed for MEDLINE]Related articles

    6.

    Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts.

    Skiest DJ, Machala T.

    J Clin Virol. 2003 Apr;26(3):307-15. Review.PMID: 12637080 [PubMed - indexed for MEDLINE]Related articles

    7.

    Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

    Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA.

    Ann Intern Med. 2000 Oct 3;133(7):493-503.PMID: 11015162 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.

    Fowke KR, D'Amico R, Chernoff DN, Pottage JC Jr, Benson CA, Sha BE, Kessler HA, Landay AL, Shearer GM.

    AIDS. 1997 Jul;11(8):1013-21.PMID: 9223736 [PubMed - indexed for MEDLINE]Related articles

    9.

    [Influenza vaccination of human immunodeficiency virus-infected patients with severe immunodepression. Impact on CD4 lymphocytes and plasma viral load]

    Gutiérrez F, Maestre A, Manuel Ramos J, Masiá M, Escolano C, Hidalgo AM.

    Med Clin (Barc). 2001 Oct 13;117(11):410-2. Spanish. PMID: 11602169 [PubMed - indexed for MEDLINE]Related articles

    10.

    Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.

    Montoya CJ, Toro MF, Aguirre C, Bustamante A, Hernandez M, Arango LP, Echeverry M, Arango AE, Prada MC, Alarcon Hdel P, Rojas M.

    Mem Inst Oswaldo Cruz. 2007 Jun;102(4):501-8.PMID: 17612772 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Randomized, placebo-controlled trial of Chinese herb therapy for HIV-1-infected individuals.

    Weber R, Christen L, Loy M, Schaller S, Christen S, Joyce CR, Ledermann U, Ledergerber B, Cone R, Lüthy R, Cohen MR.

    J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):56-64.PMID: 10534147 [PubMed - indexed for MEDLINE]Related articles

    12.

    Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.

    King JC Jr, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB.

    J Infect Dis. 2000 Feb;181(2):725-8.PMID: 10669363 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.

    Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD.

    J Infect Dis. 2000 Feb;181(2):522-31.PMID: 10669335 [PubMed - indexed for MEDLINE]Related articles

    14.

    Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response.

    Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D.

    Clin Infect Dis. 1999 Mar;28(3):541-7.PMID: 10194075 [PubMed - indexed for MEDLINE]Related articles

    15.

    Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.

    Yamanaka H, Teruya K, Tanaka M, Kikuchi Y, Takahashi T, Kimura S, Oka S; HIV/Influenza Vaccine Study Team.

    J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):167-73.PMID: 15905732 [PubMed - indexed for MEDLINE]Related articles

    16.

    Compromised B cell responses to influenza vaccination in HIV-infected individuals.

    Malaspina A, Moir S, Orsega SM, Vasquez J, Miller NJ, Donoghue ET, Kottilil S, Gezmu M, Follmann D, Vodeiko GM, Levandowski RA, Mican JM, Fauci AS.

    J Infect Dis. 2005 May 1;191(9):1442-50. Epub 2005 Mar 24.PMID: 15809902 [PubMed - indexed for MEDLINE]Related articles

    17.

    Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452).

    Autran B, Murphy RL, Costagliola D, Tubiana R, Clotet B, Gatell J, Staszewski S, Wincker N, Assoumou L, El-Habib R, Calvez V, Walker B, Katlama C; ORVACS Study Group.

    AIDS. 2008 Jul 11;22(11):1313-22.PMID: 18580611 [PubMed - indexed for MEDLINE]Related articles

    18.

    Recombinant gp160 as a therapeutic vaccine for HIV-infection: results of a large randomized, controlled trial. European Multinational IMMUNO AIDS Vaccine Study Group.

    Goebel FD, Mannhalter JW, Belshe RB, Eibl MM, Grob PJ, de Gruttola V, Griffiths PD, Erfle V, Kunschak M, Engl W.

    AIDS. 1999 Aug 20;13(12):1461-8.PMID: 10465068 [PubMed - indexed for MEDLINE]Related articles

    19.

    Influenza vaccination of HIV-1-positive and HIV-1-negative former intravenous drug users.

    Amendola A, Boschini A, Colzani D, Anselmi G, Oltolina A, Zucconi R, Begnini M, Besana S, Tanzi E, Zanetti AR.

    J Med Virol. 2001 Dec;65(4):644-8.PMID: 11745926 [PubMed - indexed for MEDLINE]Related articles

    20.

    Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.

    Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, Hu D, Tappero JW, Choopanya K; Bangkok Vaccine Evaluation Group.

    J Infect Dis. 2006 Dec 15;194(12):1661-71. Epub 2006 Nov 3.PMID: 17109337 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity